Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Rosellini Scientific Awarded an NIH SBIR Grant to Develop a New Treatment for Overactive BladderRosellini Scientific has been awarded an NIH Small Business Innovation Research (SBIR) grant to develop a new treatment for Overactive Bladder (OAB).
By: Rosellini Scientific To provide patients with a consistent, convenient, and effective therapy, Rosellini Scientific has launched nUro Inc., which is developing a non-pharmacological therapy that can be delivered at home. The nUro Inc. solution is a wireless neurostimulation system comprising a petite, implanted neurostimulator and an unobtrusive external controller, which is only worn during therapy sessions. With this system the patient is able to deliver the optimal therapy at their convenience, away from the physician’s office. This Phase I SBIR contract, which is being funded through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), will be executed under the direction of Dr. Austin Duke, VP of Emerging Therapies at Rosellini Scientific, and Dr. Paul Yoo, Assistant Research Professor at the University of Toronto. “We are extremely proud of all that we’ve accomplished to date regarding the development of the nUro Inc. wireless neurostimulator,” About Rosellini Scientific: Rosellini Scientific invests both expertise and capital in the development, management, and post-market support of medical technology. The company fosters technology development through collaborations with leading researchers, as well as partnerships with pioneering companies and universities. Rosellini Scientific is creating an active market for translational medicine that connects all stakeholders. Visit http://www.RoselliniScientific.com to learn more. Contact: William Rosellini Rosellini Scientific Dallas, TX +1 8887302437 rachaelg@roselliniscientific.com http://www.RoselliniScientific.com End
Account Phone Number Disclaimer Report Abuse
|
|